In vivo blockade of C5aR1 during the sensitization phase in OVA- and HDM-induced experimental allergic asthma models resulted in increased levels of Th2 cytokines and an overall increased airway inflammation [11]. This evidence concerns the gene C5AR1 and allergic asthma.